NA Proactive news snapshot: Binovi Technologies, Vyant Bio, Unigold, Mydecine Innovations, Naturally Splendid Enterprises ...

Binovi Technologies Corp. has provided its first response to an unsolicited bid for the company announced on Monday, August 16, 2021, by Captiva Verde Wellness Corp. The company said it has been informed by the principals that Captiva Verde intends to launch a bid to acquire the company for 7 cents worth of Captiva Verde Wellness common shares for each common share of Binovi, a 75% premium over Binovi's closing price on Friday, August 14, 2021. Binovi said it will form a special committee of the board to investigate the merits of the offer and will provide a recommendation to shareholders based on the conclusions of that exercise. In a statement, Binovi interim chief executive officer Tania Archer commented: "It is too early to state if the Captiva Verde offer, as presented, holds sufficient merit for us to recommend shareholders accept the terms. As soon as the special committee has completed its review, we will inform the market as to our position in relation to the offer. We anticipate concluding our review within the next 48 hours." Vyant Bio Inc, an emerging global drug discovery company, posted second-quarter results that demonstrated it is in a strong financial position with $26.5 million to build a “robust pipeline” of novel therapeutics targeting neurological disorders and cancers. For the period ended June 30, 2021, the Cherry Hill, New Jersey-based company had cash and cash equivalents totaling $26.5 million. As StemoniX Inc was deemed to have acquired Cancer Genetics Inc for accounting purposes, and the merger closed on March 30, 2021, the company’s 2Q financial results include the post-merger results of the combined companies, now known as Vyant Bio. Unigold Inc., a gold explorer focused on its Neita concession property in the Dominican Republic, has released the results of an exploration drill on the Candelones deposits. Highlighted in the new data were holes LP21-204 and LP21-206, which were described as collared 50 meters west of the Candelones Extension resource envelope. The recent drill is part of an exploration program designed to test the mineralization in the sparsely drilled area. Mydecine Innovations Group Inc reported its 2Q results showing the psychedelic firm ended the three-month period with C$7 million in cash and equivalents following a robust research program. The Denver, Colorado-based company said it had identified four new lead drug candidates in its portfolio and discovered more than 40 potential pharmacologically active novel compounds in mushrooms. CEO Joshua Bartach told investors that the company made “groundbreaking progress” and discoveries in its psilocybin compound research and drug development program during the three-month period to end June 30, 2021.  Naturally Splendid Enterprises Ltd. has announced the signing of the definitive agreement with Flexitarian Foods Pty. Ltd., a division of Australia's largest plant-based manufacturer, to become the exclusive Canadian manufacturer and distributor for an extensive line of plant-based, meat-alternative products. The exclusive manufacturing and distribution rights are for an initial 10-year term with a 10-year renewable term. In a statement, Naturally Splendid chief executive officer J. Craig Goodwin said: "We are more than pleased to execute this definitive agreement to be the exclusive Canadian manufacturer and distributor for this amazing line of plant-based entrees. The strategic move to become the exclusive manufacturer in addition to being the exclusive distributor, is pivotal for the Company." Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. have announced a collaboration to develop a therapy for Stargardt disease, a devastating genetic disorder that affects central vision in children and adults and often leads to blindness. The agreement allows Aequus the option to acquire the North American commercial rights to REV-0100, reVision’s proprietary Stargardt disease program. As part of the option terms, Aequus will make an initial US$400,000 equity investment in reVision, with the option to fully fund the development program in return for the North American commercial rights. Funds from the initial investment are earmarked to cover the costs of a pre-clinical toxicology study for REV-0100, which will begin in the near term.  Arcadia Biosciences reported a five-fold increase in revenue in its second quarter, mainly thanks to sales from the newly acquired portfolio of wellness brands, as well as its GoodHemp seed sales. For the three months to June 30, the maker of plant-based health and wellness products reported revenue of $1.4 million, compared to $281,000 in 2Q, 2020. Matt Plavan, CEO of Arcadia, noted that the period had been the "first time" Arcadia recorded sales from its consumer brands, representing a "key milestone in our transformation to a dynamic producer and marketer of innovative, plant-based health and wellness products". Midwest Energy Emissions Corp, also known as ME2C Environmental, has reported a 21% jump in revenue in the second quarter as its emissions business continues to grow and it also revealed it expects pilot-scale testing on its rear earth extraction technology to start later this fall. The cleantech group, which provides emissions solutions to the global power industry, posted revenue of US$2.3 million in the three months to June 30, 2021, versus US$1.9 million in 2Q, 2020. This rise was attributed mainly to the increased capacity of its customers’ coal-fired electricity generating units (EGU’s) and thus more sales of the firm's sorbent products, which reduces mercury emissions. Bragg Gaming Group Inc. said it has taken its ORYX Hub content live with Admiral Bet in Serbia, significantly enhancing the operator’s offering. Following a successful integration, Admiral Bet’s Serbian customers now have access to the wide and diverse games library offered via ORYX Hub, including unique, exclusive and localized content from ORYX RGS partners GAMOMAT, Peter & Sons, CandleBets, Golden Hero, Kalamba, Givme Games. In a statement, Chris Looney, chief commercial officer of Bragg Gaming said: “We are thrilled to have taken our ORYX Hub content live with Admiral Bet, a leading operator with a vast client base. Our games have resonated well with Serbian players since we entered the market and this partnership is a testament to the appeal of our offering with the local audience. Together with Admiral Bet, we will further strengthen the reach of our content.” ORYX Hub features 13,000-plus aggregated titles from over 100 providers, including ORYX’s proprietary games as well as a range of content from the industry’s most sought-after suppliers. The Valens Company Inc has said it continues to prepare for international industry growth with upgrades to its leading-edge research and testing facility, Valens Labs. The Kelowna, British Columbia-based producer of cannabis products said ISO/IEC 17025:2017 accredited Valens Labs' testing capabilities have been enhanced to satisfy various additional international testing requirements for finished cannabis goods to support existing and future customers looking to expand their export capabilities. The enhanced validation methods that Valens Labs now offers are in preparation for changes in certain international analytics and testing requirements. These testing methods, which have previously been validated in all five tests required by Health Canada, have been increased and are expected to be compliant for international standards in many emerging markets. Valens Labs is also CALA Certified. Vox Royalty Corp told investors it saw "record royalty revenues, record net incomes and unprecedented organic growth" in its second quarter to end-June this year. The company, which has over 50 royalties and streams spanning eight jurisdictions, recorded a net income of US$2 million in the three months, swinging from a loss of US$4.1 million in 2Q, 2020. Revenue came in at US$1.3 million for the quarter with inaugural revenues received from the Janet Ivy royalty (Australia), while Vox also noted it had lifted its production stage royalty assets from just one in May to five by the end of the period. Psyched Wellness Ltd. announced that it has submitted applications to the United States Patent and Trademark office for four further provisional patents surrounding the company's flagship product, AME-1, which is derived from the Amanita muscaria mushroom. In a statement, Jeff Stevens, CEO of Psyched Wellness, commented: "The filing of these patents marks another important milestone in the execution of Psyched's strategy, and moves us closer to being able to bring our products to market. We believe AME-1 will have a sustainable commercial and societal impact with its power to help stress relief, relaxation and restful sleeping." Empower Clinic Inc’s wholly-owned subsidiary Medi+Sure Canada Inc. has obtained a Health Canada Medical Device Establishment License (MDEL) to source class II to class IV diagnostic and therapeutic medical devices from MDALL licensed manufacturers across the world. The integrated healthcare company can then distribute these medical devices in Canada under the MediSure brand. "The achievement of MediSure receiving the new MDEL licence from Health Canada is a major accomplishment, as it complements our existing Health Canada MDALL manufacturing license, and immediately opens the door for MediSure to launch new, innovative medical device solutions into the Canadian healthcare market," said Mario Cortis, MediSure’s president. Manganese X Energy Corp said its spin-out company, Graphano Energy Ltd, has received conditional listing approval from the TSX Venture Exchange. Focused on the ethical sourcing of manganese at its Battery Hill project in New Brunswick, Manganese X announced a statutory plan of arrangement with Graphano Energy in May. The deal saw Manganese X agree to the spin-out of its Lac Aux Bouleaux graphite property, located in the province of Quebec. ElectraMeccanica Vehicles Corp. has announced the results of the company’s annual general meeting (AGM) held on August 16, 2021. The company said its shareholders voted to re-elect Paul Rivera, Bal Bhullar, Henry Reisner, Jerry Kroll, Steven Sanders, Luisa Ingargiola, Joanne Yan and Peter Savagian as directors of the company for the ensuing year. In addition, at the AGM the shareholders also approved the re-appointment of KPMG as the company’s auditor for the ensuing year and authorized the directors to fix the auditor’s remuneration. Following the AGM, the company's board met and confirmed the appointment of the following executive officers: Paul Rivera, president and chief executive officer; Kevin Pavlov, chief operating officer; Bal Bhulla, chief financial officer; Henry Reisner, executive vice-president; and Isaac Moss chief administrative officer and corporate secretary. ElectraMeccanica management also expects the re-appointment of all directors of the company to each of its current Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Steppe Gold Limited said it has filed its financial results for the quarter ended June 30, 2021. The full version of the Condensed Interim Consolidated Financial Statements and Management's Discussion & Analysis can be viewed on the company's website at www.steppegold.com or under the company's profile on SEDAR at www.sedar.com. DRDGOLD Ltd. has announced that Geoffrey Campbell’s tenure as a director and chairman of the board of directors of the company will come to an end with effect from December 1, 2021. The company said Timothy Cumming, a non-executive director of the company, will replace Campbell as chairman of the board and the nominations committee with effect from December 1, 2021. In order to ensure good corporate governance in accordance with the recommendations of the King IV Report on Corporate Governance for South Africa 2016, Edmund Jeneker will remain as the lead independent director of the company. Electric Royalties Ltd said the TSX Venture Exchange has accepted for filing documentation pertaining to a royalty portfolio sale and purchase agreement dated June 30, 2021, as amended July 15, 2021, whereby Electric Royalties Ltd. has acquired from Vox Royalty Corp. the following royalty interests: A 2.5% gross concentrate sales royalty on graphite production at the Graphmada graphite mining complex, located in Madagascar and operated by Bass Metals Ltd.; a 0.75% gross revenue royalty on graphite production at the Yalbra graphite project, located in Western Australia and owned by Buxton Resources Ltd. Under the terms of the agreement, the company has made a cash payment of $50,000 and issued to Vox an aggregate of 7,270,408 common shares of the company at a deemed price of 39.2 cents per share, based on the 10-day volume-weighted average price (VWAP) per share prior to issuance. Rio2 Ltd said the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced July 20, 2021, and July 21, 2021, which will see the 9,792,880 shares with a purchase price of 65 cents per share with one placee. Braxia Scientific Corp. has announced that its management will participate at the upcoming HC Wainwright 23rd Annual Global Investment Conference being held virtually on September 13-15, 2021. More details can be found at the following link: https://hcwevents.com/annualconference/. The company also announced that it has issued 200,000 common shares to settle the amount of $62,000 owed to an independent contractor providing medical advisory services to the company. Todos Medical, Ltd. has announced that Todos Medical will be presenting at the upcoming Emerging Growth Conference to be held on August 18, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the company’s CEO, Gerald Commissiong in real-time. Investors can register here to ensure attendance at the conference and receive any updates that are released: https://goto.webcasts.com/starthere.jsp?ei=1486517&tp_key=3bd9735fe4&sti=tomdf OTC Markets Group Inc. has announced  that Laramide Resources Ltd., a company engaged in the exploration and development of uranium assets based in the United States and Australia, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. Marc Henderson, Laramide president & CEO commented: "With our large US uranium project portfolio, and focus on expanding our exposure and profile with private and institutional US investors, we are pleased to have direct access to this transparent and efficient quotation and trading platform."